BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 36327313)

  • 1. Switching the Activity of CRISPR/Cas12a Using an Allosteric Inhibitory Aptamer for Biosensing.
    Qin P; Chen P; Deng N; Tan L; Yin BC; Ye BC
    Anal Chem; 2022 Nov; 94(45):15908-15914. PubMed ID: 36327313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamer assisted CRISPR-Cas12a strategy for small molecule diagnostics.
    Niu C; Wang C; Li F; Zheng X; Xing X; Zhang C
    Biosens Bioelectron; 2021 Jul; 183():113196. PubMed ID: 33839534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating CRISPR-Cas12a with a crRNA-Mediated Catalytic Network for the Development of a Modular and Sensitive Aptasensor.
    Shu X; Zhang D; Li X; Zheng Q; Cai X; Ding S; Yan Y
    ACS Synth Biol; 2022 Aug; 11(8):2829-2836. PubMed ID: 35946354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Customization of aptamer to develop CRISPR/Cas12a-derived ultrasensitive biosensor.
    Xing W; Li Q; Han C; Sun D; Zhang Z; Fang X; Guo Y; Ge F; Ding W; Luo Z; Zhang L
    Talanta; 2023 May; 256():124312. PubMed ID: 36738621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric Activator-Regulated CRISPR/Cas12a System Enables Biosensing and Imaging of Intracellular Endogenous and Exogenous Targets.
    Li QN; Ma AX; Wang DX; Dai ZQ; Wu SL; Lu S; Zhu LN; Jiang HX; Pang DW; Kong DM
    Anal Chem; 2024 Apr; 96(16):6426-6435. PubMed ID: 38604773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulating the
    Fei X; Lei C; Ren W; Liu X; Liu C
    Anal Chem; 2023 Aug; 95(32):12169-12176. PubMed ID: 37531567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controllable crRNA Self-Transcription Aided Dual-Amplified CRISPR-Cas12a Strategy for Highly Sensitive Biosensing of FEN1 Activity.
    Song Y; Gao K; Cai X; Cheng W; Ding S; Zhang D; Deng S
    ACS Synth Biol; 2022 Nov; 11(11):3847-3854. PubMed ID: 36240131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive aptasensing of ATP based on a PAM site-regulated CRISPR/Cas12a activation.
    Liang P; Lv B; Chen K; Li D
    Mikrochim Acta; 2024 Jun; 191(7):386. PubMed ID: 38867016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas12a-based electrochemical biosensor for highly sensitive detection of cTnI.
    Chen H; Li ZY; Chen J; Yu H; Zhou W; Shen F; Chen Q; Wu L
    Bioelectrochemistry; 2022 Aug; 146():108167. PubMed ID: 35623274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-Background CRISPR/Cas12a Sensors for Versatile Live-Cell Biosensing.
    Li QN; Wang DX; Han GM; Liu B; Tang AN; Kong DM
    Anal Chem; 2023 Oct; 95(42):15725-15735. PubMed ID: 37819747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upconversion-mediated CRISPR-Cas12a biosensing for sensitive detection of ochratoxin A.
    Mao Z; Wang X; Chen R; Zhou Z; Ren S; Liang J; Gao Z
    Talanta; 2022 May; 242():123232. PubMed ID: 35180538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas12a-mediated label-free electrochemical aptamer-based sensor for SARS-CoV-2 antigen detection.
    Liu N; Liu R; Zhang J
    Bioelectrochemistry; 2022 Aug; 146():108105. PubMed ID: 35367933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "RESET" Effect: Random Extending Sequences Enhance the Trans-Cleavage Activity of CRISPR/Cas12a.
    Ma JY; Wang SY; Du YC; Wang DX; Tang AN; Wang J; Kong DM
    Anal Chem; 2022 Jun; 94(22):8050-8057. PubMed ID: 35615910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas12a collateral cleavage activity for simple and rapid detection of protein/small molecule interaction.
    Kim H; Lee S; Yoon J; Song J; Park HG
    Biosens Bioelectron; 2021 Dec; 194():113587. PubMed ID: 34455224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Split aptamer regulated CRISPR/Cas12a biosensor for 17β-estradiol through a gap-enhanced Raman tags based lateral flow strategy.
    Li Q; Li X; Zhou P; Chen R; Xiao R; Pang Y
    Biosens Bioelectron; 2022 Nov; 215():114548. PubMed ID: 35870335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive Small Molecule Aptasensing based on Hybridization Chain Reaction and CRISPR/Cas12a Using a Portable 3D-Printed Visualizer.
    Ma L; Liao D; Zhao Z; Kou J; Guo H; Xiong X; Man S
    ACS Sens; 2023 Mar; 8(3):1076-1084. PubMed ID: 36651835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A CRISPR/Cas12a-assisted in vitro diagnostic tool for identification and quantification of single CpG methylation sites.
    van Dongen JE; Berendsen JTW; Eijkel JCT; Segerink LI
    Biosens Bioelectron; 2021 Dec; 194():113624. PubMed ID: 34534948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ratiometric fluorescent probe: a sensitive and reliable reporter for the CRISPR/Cas12a-based biosensing platform.
    Liu Q; Liu M; Jin Y; Li B
    Analyst; 2022 May; 147(11):2567-2574. PubMed ID: 35575140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNase H-Driven crRNA Switch Circuits for Rapid and Sensitive Detection of Various Analytical Targets.
    Li HD; Fang GH; Ye BC; Yin BC
    Anal Chem; 2023 Dec; 95(50):18549-18556. PubMed ID: 38073045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of antibody-aptamer sandwich-like immunosensor based on RCA and Nicked-PAM CRISPR/Cas12a system for the ultra-sensitive detection of a biomarker.
    Wang W; Geng L; Zhang Y; Shen W; Bi M; Gong T; Hu Z; Guo C; Wang T; Sun T
    Anal Chim Acta; 2023 Dec; 1283():341849. PubMed ID: 37977804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.